1
|
Safavi M, Taghipour S, Vasei M, Eshaghi H, Haghi Ashtiani MT. Evaluation of human bocavirus as well as other well-known viral etiologic agents by PCR in the cerebrospinal fluid of children with clinical impression of viral meningoencephalitis referred to the Children's Medical Center in Tehran, Iran, from 2019 to 2020. J Med Virol 2022; 94:4944-4949. [PMID: 35689362 DOI: 10.1002/jmv.27930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2021] [Revised: 06/06/2022] [Accepted: 06/09/2022] [Indexed: 11/08/2022]
Abstract
Viral meningoencephalitis is one of the most important diseases that most commonly affect children. In many cases of viral meningoencephalitis, the underlying cause of the disease is not identified, raising the possibility of a variety of pathogens that are not routinely tested. Bocaviruses belong to a newly identified class of viruses that have been reported in some studies to be associated with viral encephalitis. In the present study, we investigated the prevalence of bocaviruses and other viruses in the patients suspected of having viral encephalitis and their associations with various demographic and clinical variables. Two hundred patients with suspected viral meningoencephalitis referred to Children's Medical Center were studied from 2019 to 2020. Age, sex, length of hospitalization, and course of the disease were gathered. Cerebrospinal fluid (CSF) samples were taken from the patients and subjected to biochemical examinations and PCR to identify the underlying cause. Bocaviruses were detected in none of the DNA samples extracted from the CSF specimens. The most identified organisms were mumps and enteroviruses. In 92% of cases, the underlying cause was not identified. PCR-based identification of the underlying causes of viral meningoencephalitis in CSF specimens was not successful in most cases. Bocavirus was not found in any of the collected CSF samples. Further studies are required for drawing more accurate conclusions.
Collapse
Affiliation(s)
- Moeinadin Safavi
- Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Salameh Taghipour
- Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammad Vasei
- Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.,Cell-based Therapies Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Hamid Eshaghi
- Department of Infectious, Diseases, Pediatric's Center of Excellence, Children's Medical, Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammad Taghi Haghi Ashtiani
- Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Carneiro VCDS, Alves-Leon SV, Sarmento DJDS, Coelho WLDCNP, Moreira ODC, Salvio AL, Ramos CHF, Ramos Filho CHF, Marques CAB, da Costa Gonçalves JP, Leon LAA, de Paula VS. Herpesvirus and neurological manifestations in patients with severe coronavirus disease. Virol J 2022; 19:101. [PMID: 35676707 PMCID: PMC9174631 DOI: 10.1186/s12985-022-01828-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Accepted: 05/25/2022] [Indexed: 12/14/2022] Open
Abstract
Background Certain clinical manifestations of coronavirus disease (COVID-19) mimic those associated with human herpesvirus (HHV) infection. In this study, we estimated the prevalence of herpesvirus in patients with COVID-19 and determined if coinfection is associated with poorer outcomes and neurological symptoms. Methods We analyzed samples of 53 patients diagnosed with COVID-19. The samples were evaluated for the presence of alphaherpesviruses, betaherpesviruses, and gammaherpesviruses, and the viral loads were quantified using quantitative polymerase chain reaction (qPCR) method. Results Among the patients, in 79.2% had detection at least one type of herpesvirus. HHV-6 (47.2%), cytomegalovirus (43.3%), and HHV-7 (39.6%) showed the highest detection rates. Patients with a high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load were more likely to show herpes simplex virus 1 detection (p = 0.037). Among patients coinfected with SARS-CoV-2 and HHVs, 26.4% showed central nervous system-associated neurological symptoms and herpetic manifestations. A statistically significant association was observed between neurological changes and HHV-6 detection (p = 0.034). Conclusions The findings showed a high prevalence of herpesvirus in patients with COVID-19. Furthermore, even though SARS-CoV-2 and HHV coinfection was not associated with poorer outcomes, the findings demonstrated the association between neurological symptoms and HHV-6 detection. Supplementary Information The online version contains supplementary material available at 10.1186/s12985-022-01828-9.
Collapse
|
3
|
Central nervous system infection in the intensive care unit: Development and validation of a multi-parameter diagnostic prediction tool to identify suspected patients. PLoS One 2021; 16:e0260551. [PMID: 34843551 PMCID: PMC8629274 DOI: 10.1371/journal.pone.0260551] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Accepted: 10/26/2021] [Indexed: 12/29/2022] Open
Abstract
Background Central nervous system infections (CNSI) are diseases with high morbidity and mortality, and their diagnosis in the intensive care environment can be challenging. Objective: To develop and validate a diagnostic model to quickly screen intensive care patients with suspected CNSI using readily available clinical data. Methods Derivation cohort: 783 patients admitted to an infectious diseases intensive care unit (ICU) in Oswaldo Cruz Foundation, Rio de Janeiro RJ, Brazil, for any reason, between 01/01/2012 and 06/30/2019, with a prevalence of 97 (12.4%) CNSI cases. Validation cohort 1: 163 patients prospectively collected, between 07/01/2019 and 07/01/2020, from the same ICU, with 15 (9.2%) CNSI cases. Validation cohort 2: 7,270 patients with 88 CNSI (1.21%) admitted to a neuro ICU in Chicago, IL, USA between 01/01/2014 and 06/30/2019. Prediction model: Multivariate logistic regression analysis was performed to construct the model, and Receiver Operating Characteristic (ROC) curve analysis was used for model validation. Eight predictors—age <56 years old, cerebrospinal fluid white blood cell count >2 cells/mm3, fever (≥38°C/100.4°F), focal neurologic deficit, Glasgow Coma Scale <14 points, AIDS/HIV, and seizure—were included in the development diagnostic model (P<0.05). Results The pool data’s model had an Area Under the Receiver Operating Characteristics (AUC) curve of 0.892 (95% confidence interval 0.864–0.921, P<0.0001). Conclusions A promising and straightforward screening tool for central nervous system infections, with few and readily available clinical variables, was developed and had good accuracy, with internal and external validity.
Collapse
|
4
|
Jeffries AM, Marriott I. Cytosolic DNA Sensors and CNS Responses to Viral Pathogens. Front Cell Infect Microbiol 2020; 10:576263. [PMID: 33042875 PMCID: PMC7525022 DOI: 10.3389/fcimb.2020.576263] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Accepted: 08/12/2020] [Indexed: 12/17/2022] Open
Abstract
Viral central nervous system (CNS) infections can lead to life threatening encephalitis and long-term neurological deficits in survivors. Resident CNS cell types, such as astrocytes and microglia, are known to produce key inflammatory and antiviral mediators following infection with neurotropic DNA viruses. However, the mechanisms by which glia mediate such responses remain poorly understood. Recently, a class of intracellular pattern recognition receptors (PRRs), collectively known as DNA sensors, have been identified in both leukocytic and non-leukocytic cell types. The ability of such DNA sensors to initiate immune mediator production and contribute to infection resolution in the periphery is increasingly recognized, but our understanding of their role in the CNS remains limited at best. In this review, we describe the evidence for the expression and functionality of DNA sensors in resident brain cells, with a focus on their role in neurotropic virus infections. The available data indicate that glia and neurons can constitutively express, and/or can be induced to express, various disparate DNA sensing molecules previously described in peripheral cell types. Furthermore, multiple lines of investigation suggest that these sensors are functional in resident CNS cells and are required for innate immune responses to viral infections. However, it is less clear whether DNA sensormediated glial responses are beneficial or detrimental, and the answer to this question appears to dependent on the context of the infection with regard to the identity of the pathogen, host cell type, and host species. Defining such parameters will be essential if we are to successfully target these molecules to limit damaging inflammation while allowing beneficial host responses to improve patient outcomes.
Collapse
Affiliation(s)
- Austin M Jeffries
- Department of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC, United States
| | - Ian Marriott
- Department of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC, United States
| |
Collapse
|
5
|
Erazo Narvaez AF, Díez Chamorro LS, Ordoñez Ruiz GA, Niño Castaño VE. Meningoencefalitis por herpes simple: una visión de la infección viral que causa el mayor compromiso cerebral. REPERTORIO DE MEDICINA Y CIRUGÍA 2020. [DOI: 10.31260/repertmedcir.01217273.939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
La inflamación del sistema nervioso central secundaria a la infección por la familia herpesviridae puede generar un compromiso difuso del parénquima encefálico, la cual puede ser fatal en ausencia de un rápido diagnóstico y tratamiento. Objetivo: revisar las diferentes características biológicas, fisiopatológicas, clínicas, terapéuticas y pronóstico de la meningoencefalitis causada por VHS-1 y 2. Materiales y métodos: revisión de la literatura científica (revisión crítica), llevada a cabo mediante las bases de datos Medline y buscadores específicos IMBIOMED, PUBMEDE, SCIENCEDIRECT, SCIELO, con un total de 150 artículos, se priorizaron 67 los cuales fueron leídos a profundidad. Resultados y discusión: debido el neurotropismo del herpes virus simple puede causar neuroinvasividad, neurotoxicidad y latencia en el SNC. Por sus características semiológicas inespecíficas se requiere un estudio exhaustivo para lograr el diagnóstico acertado. Los métodos actuales tales como neuroimágenes y PCR han aportado al esclarecimiento del diagnóstico etiológico de esta patología. La detección temprana de la entidad y la instauración precoz del tratamiento, se asocian con un aumento en la tasa de supervivencia y a una disminución de las secuelas neurológicas. Conclusión: conocer la biología del virus, su comportamiento, las características clínicas y el tratamiento de la entidad es una estrategia eficaz para disminuir secuelas y desenlaces fatales.
Collapse
|
6
|
Koeller KK, Shih RY. Viral and Prion Infections of the Central Nervous System: Radiologic-Pathologic Correlation: From the Radiologic Pathology Archives. Radiographics 2017; 37:199-233. [PMID: 28076019 DOI: 10.1148/rg.2017160149] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Viral infections of the central nervous system (CNS) range in clinical severity, with the most severe proving fatal within a matter of days. Some of the more than 100 different viruses known to affect the brain and spinal cord are neurotropic with a predilection for producing CNS infection. The host response to viral infection of the CNS is responsible for the pathophysiology and imaging findings seen in affected patients. Viral CNS infections can take the form of meningitis, encephalitis, encephalomyelitis, or, when involving the spinal cord and nerve roots, encephalomyeloradiculitis. In 1982, an infectious particle termed a prion that lacked nucleic acid and therefore was not a virus was reported to produce the fatal neurodegenerative disease Creutzfeldt-Jakob disease and related disorders. These prion diseases produce characteristic neuroimaging findings that are distinct from those seen in most viral infections. The clinical and imaging findings associated with viral CNS infection are often nonspecific, with microbiologic analysis of cerebrospinal fluid the most useful single test allowing for diagnosis of a specific viral infection. This review details the spectrum of viral CNS infections and uses case material from the archives of the American Institute for Radiologic Pathology, with a focus on the specific clinical characteristics and magnetic resonance imaging features seen in these infections. Where possible, the imaging features that allow distinction of these infections from other CNS inflammatory conditions are highlighted.
Collapse
Affiliation(s)
- Kelly K Koeller
- From the Department of Neuroradiology, American Institute for Radiologic Pathology, Silver Spring, Md (K.K.K., R.Y.S.); Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (K.K.K.); Uniformed Services University of the Health Sciences, Bethesda, Md (R.Y.S.); and Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Md (R.Y.S.)
| | - Robert Y Shih
- From the Department of Neuroradiology, American Institute for Radiologic Pathology, Silver Spring, Md (K.K.K., R.Y.S.); Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (K.K.K.); Uniformed Services University of the Health Sciences, Bethesda, Md (R.Y.S.); and Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Md (R.Y.S.)
| |
Collapse
|
7
|
Abstract
Central nervous system (CNS) infections are frequently encountered in the intensive care unit setting and are a significant source of morbidity and mortality. The constantly changing trends in microbial resistance, as well as the pharmacokinetic difficulties in providing effective concentrations of antimicrobials at the site of infection represent a unique challenge to clinicians. Achievement of a successful outcome in patientswith CNS infections is reliant on eradication of the offending pathogen and management of any neurologic complications. This requires an anatomic and physiologic understanding of the different types of CNS infection, diagnostic strategies, associated complications, causative organisms, and the principles that govern drug distribution into the CNS. This article serves as a review of the epidemiology, pathophysiology, diagnosis, and treatment options for a variety of CNS infections, with a focus on those commonly encountered in an intensive care setting.
Collapse
Affiliation(s)
- John J. Lewin
- The Johns Hopkins Hospital, 600 North Wolfe St., Carnegie 180, Baltimore, MD 21287-6180
| | - Marc Lapointe
- College of Pharmacy, Department of Pharmacy and Clinical Sciences, College of Medicine, Department of Neurological Surgery, Medical University of South Carolina, Charleston
| | - Wendy C. Ziai
- Division of Neurosciences Critical Care, The Johns Hopkins Hospital, Baltimore
| |
Collapse
|
8
|
Peng J, Chen L, Zhu ZG, Zhu ZR, Hu Q, Fang Y. Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG. Hum Vaccin Immunother 2015; 10:3622-6. [PMID: 25668669 DOI: 10.4161/21645515.2014.979621] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
It has not been reported that administration of combining rabies vaccines and immunoglobulin resulted in acute disseminated encephalomyelitis (ADEM) yet. This report described that an old man acquired ADEM after being administrated with purified Vero cell rabies vaccine (PVRV) and Human Rabies Immunoglobulin (HRIG). Then he was given intravenous and oral glucocorticoids. Simultaneously, rabies vaccination was continued with purified Chick embryo cell vaccines (PCECV) instead of PVRV. Furthermore, we analyzed the rabies virus neutralizing antibodies (RVNA) levels in the patient's blood at different time points after rabies vaccination. Collectively, we observed that PCECV vaccination did not affect the prognosis of ADEM, and glucocorticoid was crucial and effective, which had no significant influence on efficacy of PCECV.
Collapse
Key Words
- ADEM
- ADEM, acute disseminated encephalomyelitis
- ANCA, Antineutrophil cytoplasmic antibodies
- ASO, Anti-streptolycin O
- CRP, C-reactive protein
- CSF, Cerebrospinal fluid
- CT, Computed tomography
- EEG, electroencephalography
- ESR, Erythrocyte sedimentation rate
- FLAIR, fluid-attenuated inversion recovery
- HDCV, human diploid cell vaccine
- HRIG
- HRIG, Human Rabies Immunoglobulin
- MRI, magnetic resonance image
- MS, multiple sclerosis
- PCECV, purified Chick embryo cell vaccines
- PEP, post-exposure prophylaxis
- PPRC, Pharmacopoeia of the People's Republic of China
- PVRV
- PVRV, purified Vero cell rabies vaccine
- RABV, rabies virus
- RFFIT, rapid fluorescent focus inhibition test
- RVNA
- RVNA, rabies virus neutralizing antibodies
- T2W, T2-weighted
- glucocorticoids
Collapse
Affiliation(s)
- Jun Peng
- a Department of Neurology; Union Hospital; Tongji Medical College ; Huazhong University of Science and Technology ; Wuhan , China
| | | | | | | | | | | |
Collapse
|
9
|
Kastrukoff LF, Lau AS, Takei F, Carbone FR, Scalzo AA. A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice. Immunol Cell Biol 2015; 93:877-84. [PMID: 25971711 DOI: 10.1038/icb.2015.54] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Revised: 05/08/2015] [Accepted: 05/10/2015] [Indexed: 11/09/2022]
Abstract
The most frequent cause of sporadic viral encephalitis in western countries is Herpes simplex virus (HSV). Despite treatment, mortality rates reach 20-30% while survivors often suffer from significant morbidity. In mice, resistance to lethal Herpes simplex encephalitis (HSE) is multifactorial and influenced by mouse and virus strain as well as route of infection. The ability to restrict viral spread in the brain is one factor contributing to resistance. After infection of the oral mucosa with HSV type 1 (HSV-1), virus spreads throughout the brains of susceptible strains but is restricted in resistant C57BL/6 mice. To further investigate restriction of viral spread in the brain, mendelian analysis was combined with studies of congenic, intra-natural killer complex (intra-NKC) recombinant and antibody-depleted mice. Results from mendelian analysis support the restriction of viral spread as a dominant trait and consistent with a single gene effect. In congenic mice, the locus maps to the NKC on chromosome 6 and is provisionally termed Herpes Resistance Locus 2 (Hrl2). In intra-NKC recombinants, the locus is further mapped to the segment Cd69 through D6Wum34; a different location from previously identified loci (Hrl and Rhs1) also associated with HSV-1 infection. Studies with antibody-depleted mice indicate the effect of this locus is mediated by NK1.1(+) expressing cells. This model increases our knowledge of lethal HSE, which may lead to new treatment options.
Collapse
Affiliation(s)
- Lorne F Kastrukoff
- Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Allen S Lau
- Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Fumio Takei
- The Terry Fox Laboratory, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
| | - Francis R Carbone
- Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
| | - Anthony A Scalzo
- Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia.,Centre for Ophthalmology and Vision Science, M517, University of Western Australia, Crawley, Western Australia, Australia
| |
Collapse
|
10
|
Olsen SJ, Campbell AP, Supawat K, Liamsuwan S, Chotpitayasunondh T, Laptikulthum S, Viriyavejakul A, Tantirittisak T, Tunlayadechanont S, Visudtibhan A, Vasiknanonte P, Janjindamai S, Boonluksiri P, Rajborirug K, Watanaveeradej V, Khetsuriani N, Dowell SF. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003-2005. Emerg Infect Dis 2015; 21:280-9. [PMID: 25627940 PMCID: PMC4313633 DOI: 10.3201/eid2102.140291] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Acute encephalitis is a severe neurologic syndrome. Determining etiology from among ≈100 possible agents is difficult. To identify infectious etiologies of encephalitis in Thailand, we conducted surveillance in 7 hospitals during July 2003-August 2005 and selected patients with acute onset of brain dysfunction with fever or hypothermia and with abnormalities seen on neuroimages or electroencephalograms or with cerebrospinal fluid pleocytosis. Blood and cerebrospinal fluid were tested for >30 pathogens. Among 149 case-patients, median age was 12 (range 0-83) years, 84 (56%) were male, and 15 (10%) died. Etiology was confirmed or probable for 54 (36%) and possible or unknown for 95 (64%). Among confirmed or probable etiologies, the leading pathogens were Japanese encephalitis virus, enteroviruses, and Orientia tsutsugamushi. No samples were positive for chikungunya, Nipah, or West Nile viruses; Bartonella henselae; or malaria parasites. Although a broad range of infectious agents was identified, the etiology of most cases remains unknown.
Collapse
Affiliation(s)
| | | | - Krongkaew Supawat
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Sahas Liamsuwan
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Tawee Chotpitayasunondh
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Somsak Laptikulthum
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Akravudh Viriyavejakul
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Tasanee Tantirittisak
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Supoch Tunlayadechanont
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Anannit Visudtibhan
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Punnee Vasiknanonte
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Supachai Janjindamai
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Pairoj Boonluksiri
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Kiatsak Rajborirug
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Veerachai Watanaveeradej
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Nino Khetsuriani
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | - Scott F. Dowell
- Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand (S.J. Olsen, S.F. Dowell)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.J. Olsen, A.P. Campbell, N. Khetsuriani, S.F. Dowell)
- Thailand Ministry of Health, Nonthaburi (K. Supawat)
- Queen Sirikit National Institute of Child Health, Bangkok (S. Liamsuwan, T. Chotpitayasunondh)
- Rajvithi Hospital, Bangkok (S. Laptikulthum)
- Prasat Neurological Institute of Thailand, Bangkok (A. Viriyavejakul, T. Tantirittisak)
- Ramathibodi Hospital, Bangkok (S. Tunlayadechanont, A. Visudtibhan)
- Prince Songkhla University Hospital, Hat Yai, Thailand (P. Vasiknanonte, S. Janjindamai)
- Hat Yai Hospital, Hat Yai (P. Boonluksiri, K. Rajborirug)
- Phramongkutklao Hospital, Bangkok (V. Watanaveeradej)
| | | |
Collapse
|
11
|
Hofert SM, Burke MG. Nothing is simple about a complex febrile seizure: looking beyond fever as a cause for seizures in children. Hosp Pediatr 2014; 4:181-187. [PMID: 24785563 DOI: 10.1542/hpeds.2013-0098] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- Sheila M Hofert
- Department of Pediatrics, St Agnes Hospital, Baltimore, Maryland; and
| | | |
Collapse
|
12
|
Conley RN, Longmuir GA. Brain and Spinal Cord. Clin Imaging 2014. [DOI: 10.1016/b978-0-323-08495-6.00033-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Hafezi W, Hoerr V. In vivo visualization of encephalitic lesions in herpes simplex virus type 1 (HSV-1) infected mice by magnetic resonance imaging (MRI). Methods Mol Biol 2013; 1064:253-65. [PMID: 23996263 DOI: 10.1007/978-1-62703-601-6_18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Herpes simplex encephalitis (HSE) is one of the most severe viral infections affecting the temporal lobes of the brain. Despite the improvements in diagnosis and antiviral drug treatment, one third of all patients fail to respond to therapy or subsequently suffer neurological relapse and develop long term neurological damage. Magnetic resonance imaging (MRI) is among the appropriate noninvasive tools for early diagnosis of viral central nervous system (CNS) infections. In this chapter we introduce a mouse model for HSE and describe a MRI protocol to characterize the pathogenesis of HSE over time.
Collapse
Affiliation(s)
- Wali Hafezi
- Institute of Medical Microbiology Clinical Virology, University Hospital Münster, Münster, Germany
| | | |
Collapse
|
14
|
Furr SR, Marriott I. Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation. Front Microbiol 2012; 3:201. [PMID: 22723794 PMCID: PMC3379540 DOI: 10.3389/fmicb.2012.00201] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2012] [Accepted: 05/15/2012] [Indexed: 12/13/2022] Open
Abstract
Viruses are the major causative agents of central nervous system (CNS) infection worldwide. RNA and DNA viruses trigger broad activation of glial cells including microglia and astrocytes, eliciting the release of an array of mediators that can promote innate and adaptive immune responses. Such responses can limit viral replication and dissemination leading to infection resolution. However, a defining feature of viral CNS infection is the rapid onset of severe neuroinflammation and overzealous glial responses are associated with significant neurological damage or even death. The mechanisms by which microglia and astrocytes perceive neurotropic RNA and DNA viruses are only now becoming apparent with the discovery of a variety of cell surface and cytosolic molecules that serve as sensors for viral components. In this review we discuss the role played by members of the Toll-like family of pattern recognition receptors (PRRs) in the inflammatory responses of glial cells to the principle causative agents of viral encephalitis. Importantly, we also describe the evidence for the involvement of a number of newly described intracellular PRRs, including retinoic acid-inducible gene I and DNA-dependent activator of IFN regulatory factors, that are thought to function as intracellular sensors of RNA and DNA viruses, respectively. Finally, we explore the possibility that cross-talk exists between these disparate viral sensors and their signaling pathways, and describe how glial cytosolic and cell surface/endosomal PRRs could act in a cooperative manner to promote the fulminant inflammation associated with acute neurotropic viral infection.
Collapse
Affiliation(s)
| | - Ian Marriott
- Department of Biology, University of North Carolina at Charlotte,Charlotte, NC, USA
| |
Collapse
|
15
|
Kastrukoff LF, Lau AS, Thomas EE. The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS). HERPESVIRIDAE 2012; 3:4. [PMID: 22449238 PMCID: PMC3355007 DOI: 10.1186/2042-4280-3-4] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/09/2011] [Accepted: 03/26/2012] [Indexed: 12/25/2022]
Abstract
BACKGROUND Mice infected with HSV-1 can develop lethal encephalitis or virus induced CNS demyelination. Multiple factors affect outcome including route of infection, virus and mouse strain. When infected with a sub-lethal dose of HSV-1 strain 2 via the oral mucosa, susceptible SJL/J, A/J, and PL/J mice develop demyelinating lesions throughout the brain. In contrast, lesions are restricted to the brainstem (BST) in moderately resistant BALB/c mice and are absent in resistant BL/6 mice. The reasons for the strain differences are unknown. METHODS In this study, we combine histology, immunohistochemistry, and in-situ hybridization to investigate the relationship between virus and the development of lesions during the early stage (< 24 days PI) of demyelination in different strains of mice. RESULTS Initially, viral DNA and antigen positive cells appear sequentially in non-contiguous areas throughout the brains of BALB/c, SJL/J, A/J, and PL/J mice but are restricted to an area of the BST of BL/6 mice. In SJL/J, A/J, and PL/J mice, this is followed by the development of 'focal' areas of virus infected neuronal and non-neuronal cells throughout the brain. The 'focal' areas follow a hierarchical order and co-localize with developing demyelinating lesions. When antigen is cleared, viral DNA positive cells can remain in areas of demyelination; consistent with a latent infection. In contrast, 'focal' areas are restricted to the BST of BALB/c mice and do not occur in BL/6 mice. CONCLUSIONS The results of this study indicate that susceptible mouse strains, infected with HSV-1 via the oral mucosa, develop CNS demyelination during the first 24 days PI in several stages. These include: the initial spread of virus and infection of cells in non-contiguous areas throughout the brain, the development of 'focal' areas of virus infected neuronal and non-neuronal cells, the co-localization of 'focal' areas with developing demyelinating lesions, and latent infection in a number of the lesions. In contrast, the limited demyelination that develops in BALB/c and the lack of demyelination in BL/6 mice correlates with the limited or lack of 'focal' areas of virus infected neuronal and non-neuronal cells in these two strains.
Collapse
Affiliation(s)
- Lorne F Kastrukoff
- Department of Medicine, University of British Columbia, Vancouver V6T 1Z3, Canada
| | - Allen S Lau
- Department of Medicine, University of British Columbia, Vancouver V6T 1Z3, Canada
| | - Eva E Thomas
- Department of Pathology, British Columbia's Children's Hospital, Vancouver V6H 3 V4, Canada
| |
Collapse
|
16
|
Huppatz C, Gawarikar Y, Levi C, Kelly PM, Williams D, Dalton C, Massey P, Givney R, Durrheim DN. Should there be a standardised approach to the diagnostic workup of suspected adult encephalitis? A case series from Australia. BMC Infect Dis 2010; 10:353. [PMID: 21159185 PMCID: PMC3018438 DOI: 10.1186/1471-2334-10-353] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2010] [Accepted: 12/15/2010] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The clinical diagnosis of encephalitis is often difficult and identification of a causative organism is infrequent. The encephalitis syndrome may herald the emergence of novel pathogens with outbreak potential. Individual treatment and an effective public health response rely on identifying a specific pathogen. In Australia there have been no studies to try to improve the identification rate of encephalitis pathogens. This study aims to review the diagnostic assessment of adult suspected encephalitis cases. METHODS A retrospective clinical audit was performed, of all adult encephalitis presentations between July 1998 and December 2007 to the three hospitals with adult neurological services in the Hunter New England area, northern New South Wales, Australia. Case notes were examined for evidence of relevant history taking, clinical features, physical examination, laboratory and neuroradiology investigations, and outcomes. RESULTS A total of 74 cases were included in the case series. Amongst suspected encephalitis cases, presenting symptoms and signs included fever (77.0%), headache (62.1%), altered consciousness (63.5%), lethargy (32.4%), seizures (25.7%), focal neurological deficits (31.1%) and photophobia (17.6%). The most common diagnostic laboratory test performed was cerebrospinal fluid (CSF) analysis (n = 67, 91%). Herpes virus polymerase chain reaction (n = 53, 71.6%) and cryptococcal antigen (n = 46, 62.2%) were the antigenic tests most regularly performed on CSF. Neuroradiological procedures employed were computerized tomographic brain scanning (n = 68, 91.9%) and magnetic resonance imaging of the brain (n = 35, 47.3%). Thirty-five patients (47.3%) had electroencephalograms. The treating clinicians suspected a specific causative organism in 14/74 cases (18.9%), of which nine (12.1%) were confirmed by laboratory testing. CONCLUSIONS The diagnostic assessment of patients with suspected encephalitis was not standardised. Appropriate assessment is necessary to exclude treatable agents and identify pathogens warranting public health interventions, such as those transmitted by mosquitoes and those that are vaccine preventable. An algorithm and guidelines for the diagnostic workup of encephalitis cases would assist in optimising laboratory testing so that clinical management can be best tailored to the pathogen, and appropriate public health measures implemented.
Collapse
Affiliation(s)
- Clare Huppatz
- Hunter New England Population Health, NSW Health, Newcastle, New South Wales, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Hoerth MT, Drazkowski JF, Sirven JI. PATIENT MANAGEMENT PROBLEM. Continuum (Minneap Minn) 2010; 16:228-41. [DOI: 10.1212/01.con.0000368241.72480.dc] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Kastrukoff LF, Lau AS, Takei F, Smyth MJ, Jones CM, Clarke SR, Carbone FR. Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice. Virology 2010; 400:248-58. [DOI: 10.1016/j.virol.2010.02.013] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2009] [Revised: 01/05/2010] [Accepted: 02/06/2010] [Indexed: 12/11/2022]
|
19
|
Petrera E, Coto CE. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res 2010; 23:1771-7. [PMID: 19441066 DOI: 10.1002/ptr.2850] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Since natural products are considered powerful sources of novel drug discovery, a partially purified extract (meliacine) from the leaves of Melia azedarach L., a plant used in traditional medicine in India for the treatment of several diseases, has been studied. Meliacine exhibits a potent antiviral effect against several viruses without displaying cytotoxicity. The purpose of the present study was to evaluate the therapeutic effect of intravaginal administration of meliacine in a mouse model of genital herpetic infection. BALB/c female mice were infected with MS or G strains of Herpes Simplex Virus type 2 and then treated with meliacine topically. An overall protective effect was observed. Animal survival increased, the severity of the disease was reduced, life span was extended and virus shedding in vagina fluids was diminished. In addition, meliacine reduced the amount of virus that migrated to the brain and vaginal fluids presented higher levels of IFN-gamma and TNF-alpha than untreated infected mice. These results indicate that meliacine could be an alternative therapeutic compound against HSV-2 genital infection.
Collapse
Affiliation(s)
- Erina Petrera
- Laboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, Piso 4, Intendente Güiraldes 2160, C1428EGA, Buenos Aires, Argentina.
| | | |
Collapse
|
20
|
Tattevin P. Méningoencéphalites infectieuses de l’adulte non immunodéprimé. Rev Med Interne 2009; 30:125-34. [DOI: 10.1016/j.revmed.2008.05.021] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 05/09/2008] [Accepted: 05/14/2008] [Indexed: 10/21/2022]
|
21
|
Abstract
Central nervous system (CNS) infections presenting to the emergency room include meningitis, encephalitis, brain and spinal epidural abscess, subdural empyema, and ventriculitis. These conditions often require admission to an intensive care unit (ICU) and are complications of ICU patients with neurologic injury, contributing significantly to morbidity and mortality. Reducing morbidity and mortality is critically dependent on rapid diagnosis and, perhaps more importantly, on the timely initiation of appropriate antimicrobial therapy. New insights into the role of inflammation and the immune response in CNS infections have contributed to development of new diagnostic strategies using markers of inflammation, and to the study of agents with focused immunomodulatory activity, which may lead to further adjunctive therapy in human disease.
Collapse
|
22
|
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 2008; 82:7078-88. [PMID: 18480436 DOI: 10.1128/jvi.00619-08] [Citation(s) in RCA: 102] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
This study was undertaken to investigate possible immune mechanisms in fatal herpes simplex virus type 1 (HSV-1) encephalitis (HSE) after HSV-1 corneal inoculation. Susceptible 129S6 (129) but not resistant C57BL/6 (B6) mice developed intense focal inflammatory brain stem lesions of primarily F4/80(+) macrophages and Gr-1(+) neutrophils detectable by magnetic resonance imaging as early as day 6 postinfection (p.i.). Depletion of macrophages and neutrophils significantly enhanced the survival of infected 129 mice. Immunodeficient B6 (IL-7R(-/-) Kit(w41/w41)) mice lacking adaptive cells (B6-E mice) and transplanted with 129 bone marrow showed significantly accelerated fatal HSE compared to B6-E mice transplanted with B6 marrow or control nontransplanted B6-E mice. In contrast, there was no difference in ocular viral shedding in B6-E mice transplanted with 129 or B6 bone marrow. Acyclovir treatment of 129 mice beginning on day 4 p.i. (24 h after HSV-1 first reaches the brain stem) reduced nervous system viral titers to undetectable levels but did not alter brain stem inflammation or mortality. We conclude that fatal HSE in 129 mice results from widespread damage in the brain stem caused by destructive inflammatory responses initiated early in infection by massive infiltration of innate cells.
Collapse
|
23
|
|
24
|
Abstract
Encephalitis means inflammation of the brain matter. Despite being a rare condition, encephalitis is of public health importance worldwide because it has high morbidity and mortality. Yet, many details about its epidemiology have yet to be elucidated. This review attempts to summarise what is known about the epidemiology of the infective causes of encephalitis and is based on a literature search of the Medline archives. Infection is the most common cause identified, with viruses being the most important known aetiological agents. Incidence varies between studies but is generally between 3.5 and 7.4 per 100,000 patient-years. Encephalitis affects peoples of all ages; however, incidence is higher in the paediatric population. Although both sexes are affected, most studies have shown a slight predominance in males. Encephalitis occurs worldwide; some aetiologies have a global distribution (herpesviruses) while others are geographically restricted (arboviruses). Although definite epidemiological trends are evident, it is difficult to make generalisations as few population-based studies exist, most cases are not reported to health authorities, and many possible pathogens are implicated but in most cases a cause is never found. A better understanding of the epidemiology of this devastating disease will pave the way for better prevention and control strategies.
Collapse
Affiliation(s)
- Julia Granerod
- Health Protection Agency, Centre for Infections, London, UK.
| | | |
Collapse
|
25
|
Ziai WC, Lewin JJ. Advances in the management of central nervous system infections in the ICU. Crit Care Clin 2007; 22:661-94; abstract viii-ix. [PMID: 17239749 DOI: 10.1016/j.ccc.2006.11.009] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
This chapter focuses on early aggressive management of common infections of the central nervous system that require monitoring in an ICU setting. These include meningitis, encephalitis, brain and epidural abscess, subdural empyema and ventriculitis. It emphasizes priorities in evaluation and management due to increasing morbidity and mortality as a result of failure to appreciate non-specific symptoms or administer timely therapy. The emergence of organisms resistant to penicillin and cephalosporins has also further complicated the early management of bacterial meningitis. Current antimicrobial guidelines are provided along with discussion of new diagnostic and therapeutic strategies and controversial aspects of management.
Collapse
Affiliation(s)
- Wendy C Ziai
- Division of Neurosciences Critical Care, Department of Neurology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
| | | |
Collapse
|
26
|
Wang IJ, Lee PI, Huang LM, Chen CJ, Chen CL, Lee WT. The correlation between neurological evaluations and neurological outcome in acute encephalitis: a hospital-based study. Eur J Paediatr Neurol 2007; 11:63-9. [PMID: 17240177 DOI: 10.1016/j.ejpn.2006.09.010] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2006] [Revised: 09/28/2006] [Accepted: 09/29/2006] [Indexed: 11/30/2022]
Abstract
Acute encephalitis is a common CNS infectious disease in children. However, there are limited studies concerning about the correlation between the clinical evaluations and neurological outcome. To investigate the value of neurological evaluations, and the correlation between these evaluations and neurological outcomes of acute encephalitis, in the present study we retrospectively evaluated the neurological outcome of 0- to 16-year-old children with encephalitis or meningoencephalitis between 1999 and 2000. Of 101 children enrolled, 4 died and 25 had other neurological sequelae, including epilepsy, headache, developmental delay, and emotional or behavioral changes during the 5 years of follow-up. The causative organisms in patients with neurological sequelae were herpes virus (HSV) 2/2 (100%), influenza 2/3 (67%), mycoplasma 5/12 (42%), and enterovirus 71 2/7 (29%). The important predictors for adverse outcomes were focal neurological signs, multiple seizures or status epilepticus on admission, leukopenia, focal slow waves or continuous generalized delta waves in electroencephalography (EEG), and focal cortical parenchymal hyperintensity in the magnetic resonance imaging (MRI) (p<0.05). Patients with initial presentations of focal neurological signs, papilledema, myoclonic jerks, and status epilepticus tended to have higher incidence of abnormal findings in brain MRI, although not achieving statistic significances. In addition, children with focal spikes or continuous generalized delta waves in EEG also had higher incidence of MRI abnormalities. We conclude that brain MRI studies may be indicated in patients with focal neurological signs, intractable seizure, and focal spikes, focal delta waves, or continuous generalized delta waves in EEG. For those with MRI examinations, focal cortical hyperintensity suggests poorer neurological outcomes.
Collapse
Affiliation(s)
- I-Jen Wang
- Department of Pediatrics, Taipei Hospital, Department of Health, Taipei, Taiwan
| | | | | | | | | | | |
Collapse
|
27
|
Leyssen P, Croes R, Rau P, Heiland S, Verbeken E, Sciot R, Paeshuyse J, Charlier N, De Clercq E, Meyding‐Lamadé U, Neyts J. Acute encephalitis, a poliomyelitis-like syndrome and neurological sequelae in a hamster model for flavivirus infections. Brain Pathol 2006; 13:279-90. [PMID: 12946018 PMCID: PMC8095928 DOI: 10.1111/j.1750-3639.2003.tb00028.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Infection of hamsters with the murine flavivirus Modoc results in (meningo)encephalitis, which is, during the acute phase, frequently associated with flaccid paralysis, as also observed in patients with West Nile virus encephalitis. Twenty percent of the hamsters that recover from the acute encephalitis develop life-long neurological sequelae, reminiscent of those observed, for example, in survivors of Japanese encephalitis. Magnetic resonance imaging and histology revealed severe lesions predominantly located in the olfactory-limbic system, both in hamsters with acute encephalitis as in survivors. Prominent pathology was also detected in the spinal cord of hamsters with paralysis. Modoc virus infections in hamsters provide a unique model for the study of encephalitis, a poliomyelitis-like syndrome and neurological sequelae following flavivirus infection.
Collapse
Affiliation(s)
- Pieter Leyssen
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| | - Romaric Croes
- Department of Morphology and Molecular Pathology, Katholieke Universiteit Leuven, Belgium
| | - Philipp Rau
- Department of Neurology, University of Heidelberg, Germany
| | - Sabine Heiland
- Department of Neurology, University of Heidelberg, Germany
| | - Erik Verbeken
- Department of Morphology and Molecular Pathology, Katholieke Universiteit Leuven, Belgium
| | - Raphael Sciot
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| | - Jan Paeshuyse
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| | - Nathalie Charlier
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| | - Erik De Clercq
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| | | | - Johan Neyts
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
| |
Collapse
|
28
|
Papakostas YG, Daras MD, Liappas IA, Markianos M. Horse madness (hippomania) and hippophobia. HISTORY OF PSYCHIATRY 2005; 16:467-71. [PMID: 16482685 DOI: 10.1177/0957154x05051459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
Anthropophagic horses have been described in classical mythology. From a current perspective, two such instances are worth mentioning and describing: Glaucus of Potniae, King of Efyra, and Diomedes, King of Thrace, who were both devoured by their horses. In both cases, the horses' extreme aggression and their subsequent anthropophagic behaviour were attributed to their madness (hippomania) induced by the custom of feeding them with flesh. The current problem of 'mad cow' disease (bovine spongiform encephalopathy) is apparently related to a similar feed pattern. Aggressive behaviour in horses can be triggered by both biological and psychological factors. In the cases cited here, it is rather unlikely that the former were the cause. On the other hand, the multiple abuses imposed on the horses, coupled with people's fantasies and largely unconscious fears (hippophobia), may possibly explain these mythological descriptions of 'horse-monsters'.
Collapse
|
29
|
Buursma AR, de Vries EFJ, Garssen J, Kegler D, van Waarde A, Schirm J, Hospers GAP, Mulder NH, Vaalburg W, Klein HC. [18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis. J Virol 2005; 79:7721-7. [PMID: 15919924 PMCID: PMC1143670 DOI: 10.1128/jvi.79.12.7721-7727.2005] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Herpes simplex virus type 1 (HSV-1) is one of the most common causes of sporadic encephalitis. The initial clinical course of HSV encephalitis (HSE) is highly variable, and the infection may be rapidly fatal. For effective treatment with antiviral medication, an early diagnosis of HSE is crucial. Subtle brain infections with HSV may be causally related to neuropsychiatric disorders such as Alzheimer's dementia. We investigated the feasibility of a noninvasive positron emission tomography (PET) imaging technique using [(18)F]FHPG as a tracer for the detection of HSE. For this purpose, rats received HSV-1 (infected group) or phosphate-buffered saline (control group) by intranasal application, and dynamic PET scans were acquired. In addition, the distribution of tracer accumulation in specific brain areas was studied with phosphor storage imaging. The PET images revealed that the overall brain uptake of [(18)F]FHPG was significantly higher for the infected group than for control animals. Phosphor storage images showed an enhanced accumulation of [(18)F]FHPG in regions known to be affected after intranasal infection with HSV. High-performance liquid chromatography metabolite analysis showed phosphorylated metabolites of [(18)F]FHPG in infected brains, proving that the increased [(18)F]FHPG uptake in infected brains was due to HSV thymidine kinase-mediated trapping. Freeze lesion experiments showed that damage to the blood-brain barrier could in principle induce elevated [(18)F]FHPG uptake, but this nonspecific tracer uptake could easily be discriminated from HSE-derived uptake by differences in the tracer kinetics. Our results show that [(18)F]FHPG PET is a promising tool for the detection of HSV encephalitis.
Collapse
Affiliation(s)
- A R Buursma
- PET Center, Groningen University Hospital, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Campos Villarino L, Serena Puig A, Romero López J, Nogueiras Alonso JM, Outomuro Pérez J. [99mTc-HMPAO brain SPECT in a case of HSV encephalitis]. ACTA ACUST UNITED AC 2005; 24:199-203. [PMID: 15847788 DOI: 10.1157/13073792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We present a case of encephalitis caused by Herpes Simplex Virus in a 57 year old woman. The acute picture was suggestive of viral infection without associated neurological symptoms. Due to the posterior appearance of neurological focality, cerebral spinal fluid (CSF) was analyzed. It showed pleocytosis and lymphocytosis, inflammatory process data, and serological test with positivity for Simple Herpes Virus (SHV) subtypes I and II. During admission, other complementary tests were performed: EEG, CT, MRI, cerebral perfusion SPECT; the later supplied significant data regarding anatomical neuroimaging (CT, MRI) in regards to bihemispheral extension of the encephalic condition. Furthermore, after clinical discharge, persistent metabolic abnormality was demonstrated in temporal cortex, responsible for concomitant mixed aphasia.
Collapse
MESH Headings
- Antibodies, Viral/blood
- Aphasia/etiology
- Brain/blood supply
- Brain/diagnostic imaging
- Brain/pathology
- Brain/virology
- Cerebrospinal Fluid/cytology
- Cerebrovascular Circulation
- Electroencephalography
- Encephalitis, Herpes Simplex/cerebrospinal fluid
- Encephalitis, Herpes Simplex/complications
- Encephalitis, Herpes Simplex/diagnostic imaging
- Encephalitis, Herpes Simplex/virology
- Female
- Herpesvirus 1, Human/immunology
- Herpesvirus 1, Human/isolation & purification
- Herpesvirus 2, Human/immunology
- Herpesvirus 2, Human/isolation & purification
- Humans
- Leukocytosis/etiology
- Magnetic Resonance Imaging
- Middle Aged
- Radiopharmaceuticals/therapeutic use
- Technetium Tc 99m Exametazime
- Temporal Lobe/diagnostic imaging
- Temporal Lobe/pathology
- Tomography, Emission-Computed, Single-Photon
- Tomography, X-Ray Computed
Collapse
|
31
|
Buursma AR, van Dillen IJ, van Waarde A, Vaalburg W, Hospers GAP, Mulder NH, de Vries EFJ. Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport. Br J Cancer 2005; 91:2079-85. [PMID: 15599382 PMCID: PMC2409793 DOI: 10.1038/sj.bjc.6602216] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Favourable pharmacokinetics of the prodrug are essential for successful HSVtk/ganciclovir (GCV) suicide gene therapy. [18F]FHPG PET might be a suitable technique to assess the pharmacokinetics of the prodrug GCV noninvasively, provided that [18F]FHPG mimics the behaviour of GCV. Since membrane transport is an important aspect of the pharmacokinetics of the prodrug, we investigated the cellular uptake mechanism of [18F]FHPG in an HSVtk expressing C6 rat glioma cell line and in tumour-bearing rats. The nucleoside transport inhibitors dipyridamol, NBMPR and 2-chloroadenosine did not significantly affect the [18F]FHPG uptake in vitro. Thymidine and uridine significantly decreased [18F]FHPG uptake by 84 and 58%, respectively, but an enzyme assay revealed that this decline was due to inhibition of the HSVtk enzyme rather than membrane transport. Nucleobase transport inhibitors, thymine and adenine, caused a 58 and 55% decline in tracer uptake, respectively. In vivo, the ratio of [18F]FHPG uptake in C6tk and C6 tumours decreased from 3.0±0.5 to 1.0±0.2 after infusion of adenine. Thus, in our tumour model, [18F]FHPG transport exclusively occurred via purine nucleobase transport. In this respect, FHPG does not resemble GCV, which is predominantly taken up via the nucleoside transporter, but rather acyclovir, which is also taken up via the purine nucleobase carrier.
Collapse
Affiliation(s)
- A R Buursma
- PET Center, Groningen University Hospital, PO Box 30.001, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
| | | | | | | | | | | | | |
Collapse
|
32
|
Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2005; 17:903-25, table of contents. [PMID: 15489354 PMCID: PMC523566 DOI: 10.1128/cmr.17.4.903-925.2004] [Citation(s) in RCA: 145] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Hundreds of viruses cause central nervous system (CNS) disease, including meningoencephalitis and postinfectious encephalomyelitis, in humans. The cerebrospinal fluid (CSF) is abnormal in >90% of cases; however, routine CSF studies only rarely lead to identification of a specific etiologic agent. Diagnosis of viral infections of the CNS has been revolutionized by the advent of new molecular diagnostic technologies to amplify viral nucleic acid from CSF, including PCR, nucleic acid sequence-based amplification, and branched-DNA assay. PCR is ideally suited for identifying fastidious organisms that may be difficult or impossible to culture and has been widely applied for detection of both DNA and RNA viruses in CSF. The technique can be performed rapidly and inexpensively and has become an integral component of diagnostic medical practice in the United States and other developed countries. In addition to its use for identification of etiologic agents of CNS disease in the clinical setting, PCR has also been used to quantitate viral load and monitor duration and adequacy of antiviral drug therapy. PCR has also been applied in the research setting to help discriminate active versus postinfectious immune-mediate disease, identify determinants of drug resistance, and investigate the etiology of neurologic disease of uncertain cause. This review discusses general principles of PCR and reverse transcription-PCR, including qualitative, quantitative, and multiplex techniques, with comment on issues of sensitivity, specificity, and positive and negative predictive values. The application of molecular diagnostic methods for diagnosis of specific infectious entities is reviewed in detail, including viruses for which PCR is of proven efficacy and is widely available, viruses for which PCR is less widely available or for which PCR has unproven sensitivity and specificity, and nonviral entities which can mimic viral CNS disease.
Collapse
Affiliation(s)
- Roberta L Debiasi
- Department of Pediatrics, Division of Infectious Diseases, University of Colorado Health Sciences Center, Box A036/B055, Denver, CO 80262, USA.
| | | |
Collapse
|
33
|
Lee BY, Newberg AB, Liebeskind DS, Kung J, Alavi A. FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med 2005; 29:620-5. [PMID: 15365433 DOI: 10.1097/00003072-200410000-00004] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
PURPOSE Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) may be used to establish a diagnosis of encephalitis, yet prior descriptions are mainly limited to small case reports. We explore the role of FDG-PET in the diagnostic evaluation of encephalitis. METHODS Brain FDG-PET was acquired in a consecutive case series of 10 cases of suspected encephalitis over a 5-year-period. Cases with positive Lyme serology were excluded. Two expert reviewers graded the FDG-PET studies in blinded fashion with respect to the clinical history. Retrospective review of the clinical history and examination, laboratory findings, electroencephalogram (EEG), and magnetic resonance imaging (MRI) studies was performed. A diagnosis of encephalitis was based on a combination of the clinical and diagnostic examination findings in each case. RESULTS Encephalitis was diagnosed in 6 of 10 cases. FDG-PET hypermetabolism was demonstrated in 5 cases of encephalitis, most frequently involving the medial temporal lobes. Multifocal hypometabolism was noted in at least 2 regions in all 6 cases of encephalitis, with at least 4 regions of hypometabolism noted in 5 of 6 cases. Nonencephalitis cases revealed hypermetabolism in only 1 of 4 cases, ascribed to status epilepticus. Hypometabolism was evident in all nonencephalitis cases. CONCLUSION Encephalitis frequently manifests as FDG-PET hypermetabolism, but focal hypometabolism can also be observed. Seizure activity must be excluded as a possible cause of hypermetabolism in patients suspected of having encephalitis. Because other conditions that can cause hypometabolism may mimic encephalitis clinically, FDG-PET is more likely to serve as an adjunct to lumbar puncture, EEG, and clinical findings rather than a primary diagnostic tool in the management of patients suspected of having encephalitis.
Collapse
Affiliation(s)
- Bruce Y Lee
- Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | | | | | | | | |
Collapse
|
34
|
Irusta PM, Hardwick JM. Neuronal apoptosis pathways in Sindbis virus encephalitis. PROGRESS IN MOLECULAR AND SUBCELLULAR BIOLOGY 2004; 36:71-93. [PMID: 15171608 DOI: 10.1007/978-3-540-74264-7_5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Sindbis virus infects neurons of the brain and spinal cord leading to neuronal apoptosis and encephalitis in mice. During postnatal development, neurons of mice remain susceptible to infection but become refractory to SV-induced programmed cell death. Failure to undergo programmed cell death results in a persistent infection. However, some neurovirulent strains of Sindbis virus overcome the age-dependent protective function in neurons, leading to enhanced apoptotic cell death in the central nervous system and higher mortality rates. Sindbis virus infections can also cause hind-limb paralysis due to the death of infected spinal cord motor neurons. However, spinal cord neuron death in older mice appears to occur by mechanisms that differ from classical apoptosis observed in newborn mice based on the morphology of dying neurons at these two sites. Sindbis virus infections of mosquitoes and some mosquito cell lines, on the other hand, do not induce cell death but persistent infections, a phenomenon also observed occasionally in cultured mammalian cells as well as in brains of infected mice surviving lethal infections. Thus, both viral and cellular factors contribute to the varied outcomes of infection. The molecular mechanisms that govern the susceptibility or resistance of particular cell types to SV-induced cell death are not well understood. Furthermore, the cellular execution machinery that produces the characteristic morphological distinctions between brain and spinal cord (i.e. apoptotic versus non-apoptotic) remain to be discovered.
Collapse
Affiliation(s)
- Pablo M Irusta
- Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe St., Baltimore, Maryland 21205, USA.
| | | |
Collapse
|
35
|
Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 2003; 73:176-87. [PMID: 12836160 DOI: 10.1002/jnr.10635] [Citation(s) in RCA: 132] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Transgenic mice with glial fibrillary acidic protein (GFAP) promoter driven-astrocyte production of the cytokines interleukin-6 (IL-6) and tumor necrosis factor (TNF) were used to determine whether the pre-existing production of these cytokines in vivo might modulate the sensitivity of neurons to excitotoxic agents. Low doses of kainic acid (5 mg/kg) that produced little or no behavioral or electroencephalogram (EEG) alterations in wild type or glial fibrillary acidic protein (GFAP)-TNF animals induced severe tonic-clonic seizures and death in GFAP-IL6 transgenic mice of 2 or 6 months of age. GFAP-IL6 mice were also significantly more sensitive to N-methyl-D-aspartate (NMDA)- but not pilocarpine-induced seizures. Kainic acid uptake in the brain of the GFAP-IL6 mice was higher in the cerebellum but not in other regions. Kainic acid binding in the brain of GFAP-IL6 mice had a similar distribution and density as wild type controls. In the hippocampus of GFAP-IL6 mice that survived low dose kainic acid, there was no change in the extent of either neurodegeneration or astrocytosis. Immunostaining revealed degenerative changes in gamma aminobutyric acid (GABA)- and parvalbumin-positive neurons in the hippocampus of 2-month-old GFAP-IL6 mice which progressed to the loss of these cells at 6 months of age. Thus, GFAP-IL6 but not GFAP-TNF mice showed markedly enhanced sensitivity to glutamatergic- but not cholinergic-induced seizures and lethality. This may relate, in part, to a compromise of inhibitory interneuron function. Therefore, pre-existing IL-6 production and inflammation in the central nervous system (CNS) not only causes spontaneous neurodegeneration but also synergizes with other neurotoxic insults to induce more severe acute functional neurological impairment.
Collapse
Affiliation(s)
- Helen Samland
- Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA
| | | | | | | | | | | |
Collapse
|
36
|
Davison KL, Crowcroft NS, Ramsay ME, Brown DWG, Andrews NJ. Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis 2003; 9:234-40. [PMID: 12603996 PMCID: PMC2901942 DOI: 10.3201/eid0902.020218] [Citation(s) in RCA: 124] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
We analyzed hospitalizations in England from April 1, 1989, to March 31, 1998, and identified approximately 700 cases, 46 fatal, from viral encephalitis that occurred during each year; most (60%) were of unknown etiology. Of cases with a diagnosis, the largest proportion was herpes simplex encephalitis. Using normal and Poisson regression, we identified six possible clusters of unknown etiology. Over 75% of hospitalizations are not reported through the routine laboratory and clinical notification systems, resulting in underdiagnosis of viral encephalitis in England. Current surveillance greatly underascertains incidence of the disease and existence of clusters; in general, outbreaks are undetected. Surveillance systems must be adapted to detect major changes in epidemiology so that timely control measures can be implemented.
Collapse
Affiliation(s)
- Katy L Davison
- Public Health Laboratory Service Communicable Disease Surveillance Centre, London, United Kingdom.
| | | | | | | | | |
Collapse
|
37
|
Selected Disorders of the Nervous System. Fam Med 2003. [DOI: 10.1007/978-0-387-21744-4_68] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Labrada L, Liang XH, Zheng W, Johnston C, Levine B. Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J Virol 2002; 76:11688-703. [PMID: 12388728 PMCID: PMC136759 DOI: 10.1128/jvi.76.22.11688-11703.2002] [Citation(s) in RCA: 96] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Several different mammalian neurotropic viruses produce an age-dependent encephalitis characterized by more severe disease in younger hosts. To elucidate potential factors that contribute to age-dependent resistance to lethal viral encephalitis, we compared central nervous system (CNS) gene expression in neonatal and weanling mice that were either mock infected or infected intracerebrally with a recombinant strain, dsTE12Q, of the prototype alphavirus Sindbis virus. In 1-day-old mice, infection with dsTE12Q resulted in rapidly fatal disease associated with high CNS viral titers and extensive CNS apoptosis, whereas in 4-week-old mice, dsTE12Q infection resulted in asymptomatic infection with lower CNS virus titers and undetectable CNS apoptosis. GeneChip expression comparisons of mock-infected neonatal and weanling mouse brains revealed developmental regulation of the mRNA expression of numerous genes, including some apoptosis regulatory genes, such as the proapoptotic molecules caspase-3 and TRAF4, which are downregulated during development, and the neuroprotective chemokine, fractalkine, which is upregulated during postnatal development. In parallel with increased neurovirulence and increased viral replication, Sindbis virus infection in 1-day-old mice resulted in both a greater number of host inflammatory genes with altered expression and greater changes in levels of host inflammatory gene expression than infection in 4-week-old mice. Only one inflammatory response gene, an expressed sequence tag similar to human ISG12, increased by a greater magnitude in infected 4-week-old mouse brains than in infected 1-day-old mouse brains. Furthermore, we found that enforced neuronal ISG12 expression results in a significant delay in Sindbis virus-induced death in neonatal mice. Together, our data identify genes that are developmentally regulated in the CNS and genes that are differentially regulated in the brains of different aged mice in response to Sindbis virus infection.
Collapse
Affiliation(s)
- Lucia Labrada
- Department of Medicine, Columbia University College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
| | | | | | | | | |
Collapse
|
39
|
Straight TM, Lazarus AA, Decker CF. Defending against viruses in biowarfare. How to respond to smallpox, encephalitides, hemorrhagic fevers. Postgrad Med 2002; 112:75-6, 79-80, 85-6. [PMID: 12198755 DOI: 10.3810/pgm.2002.08.1276] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The threat of bioterrorism with use of viruses is increasing. Smallpox, encephalitis, and hemorrhagic fevers are the most likely diseases to result from viral deployment. It is critical that all healthcare professionals become familiar with the clinical presentation, diagnosis, management, and prevention of these diseases. Awareness and preparedness are instrumental in reducing viral transmission and improving survival of the victims.
Collapse
Affiliation(s)
- Timothy M Straight
- Department of Medicine, Infectious Disease Service, Walter Reed Army Medical Center, 6800 Georgia Ave, Washington, DC 20317, USA.
| | | | | |
Collapse
|
40
|
Beaman MH, Wesselingh SL. 4: Acute community-acquired meningitis and encephalitis. Med J Aust 2002; 176:389-96. [PMID: 12041637 DOI: 10.5694/j.1326-5377.2002.tb04462.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2001] [Accepted: 12/10/2001] [Indexed: 11/17/2022]
Abstract
Acute meningitis and encephalitis are medical emergencies that require prompt assessment (usually by cerebral imaging and lumbar puncture) and treatment; specialist consultation is recommended. In acute meningitis, early administration of antibiotics can be life-saving (usually high-dose penicillin and/or a third-generation cephalosporin); antibiotics may be needed before referral to hospital. Emergence of penicillin and cephalosporin resistance in Streptococcus pneumoniae has necessitated more complex antibiotic regimens that include vancomycin or rifampicin for empirical treatment of meningitis. Adjunctive dexamethasone therapy may be of benefit in children with Haemophilus influenzae meningitis; there is no controlled evidence of its benefit in adults, but it could be considered in those with raised intracranial pressure. In possible encephalitis, empirical therapy with intravenous aciclovir should be given to cover herpes simplex virus (HSV) until the cause is established; HSV encephalitis may be fatal and leaves up to 50% of survivors with long-term sequelae.
Collapse
Affiliation(s)
- Miles H Beaman
- Department of Infectious Diseases, Fremantle Hospital, WA.
| | | |
Collapse
|
41
|
Abstract
St. Louis encephalitis virus is a major cause of epidemic arboviral encephalitis in the US. Transmitted by a mosquito vector, this virus is an annual public health concern during the late summer and early fall in much of the midwest and southeast. The characteristic epidemic features of this viral encephalitis coupled with public health surveillance and vector monitoring programs have made the diagnosis readily accessible during the past decade. Recently, however, the arboviral landscape in the US changed dramatically with the emergence and persistence of West Nile virus and associated human neurologic illness in New York and the Northeast. In its New York presentation, West Nile virus encephalitis exhibited clinical and laboratory similarities to St. Louis encephalitis. Not surprisingly, this led to initial confusion in establishing the diagnosis. In anticipation of the potential geographic spread of West Nile virus beyond the northeastern US, neurologists must now consider West Nile virus along with St. Louis encephalitis when diagnosing patients with suspected epidemic mosquito-borne viral encephalitis or meningoencephalitis. Although no specific antiviral agents are yet available, patients will benefit from close monitoring during the initial phase of illness, supportive critical care, and appropriate rehabilitation.
Collapse
Affiliation(s)
- Micheline McCarthy
- Department of Neurology, University of Miami School of Medicine and Miami Veterans Affairs Medical Center, 1201 NW 16th Street, Miami, FL 33125, USA.
| |
Collapse
|
42
|
Goldshteyn N, Hinedi T, Abter EI, Ghitan M, Chapnick EK, Edwards J. A Case of Herpes Simplex Virus???1 Encephalitis Amidst the West Nile Virus Epidemic. INFECTIOUS DISEASES IN CLINICAL PRACTICE 2001. [DOI: 10.1097/00019048-200108000-00008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
43
|
Abstract
Over 100 viruses have been associated with acute central nervous system infections. The present review focuses on some of the most common agents of viral encephalitis, as well as important emerging viral encephalitides. In this context, the initial detection of West Nile virus in the Western Hemisphere during the 1999 New York City outbreak, the first description of Nipah virus in Malaysia, and the appearance in Asia of a new neurovirulent enterovirus 71 strain that causes severe neurologic disease are highlighted. In addition, advances regarding diagnosis, neuroimaging and treatment of Japanese and herpes simplex encephalitis are presented.
Collapse
Affiliation(s)
- V K Hinson
- Medical University of South Carolina, Department of Neurology, Charleston 29425-2232, USA
| | | |
Collapse
|
44
|
Abstract
Varicella-zoster virus (VZV), a member of the human herpesvirus family, causes childhood chickenpox (varicella), becomes latent in sensory ganglia, and reactivates years later in immunocompromised and elderly persons to produce shingles (herpes zoster). Early in the AIDS epidemic, zoster was noted in adults and children infected with HIV. Severe and debilitating zoster-associated dermatological, ophthalmic, and neurological complications may occur in patients infected with HIV. Antiviral therapy can modify the duration of zoster and alleviate its attendant complications. Varicella vaccine may boost the immunity and prevent virus reactivation. VZV immune globulin (VZIG) prevents or modifies clinical illness in persons who have been exposed to varicella or zoster.
Collapse
Affiliation(s)
- A Vafai
- Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
| | | |
Collapse
|